β-III-spectrin N-terminus is required for high-affinity actin binding and SCA5 neurotoxicity

Abstract Recent structural studies of β-III-spectrin and related cytoskeletal proteins revealed N-terminal sequences that directly bind actin. These sequences are variable in structure, and immediately precede a conserved actin-binding domain composed of tandem calponin homology domains (CH1 and CH2...

Full description

Bibliographic Details
Main Authors: Sarah A. Denha, Alexandra E. Atang, Thomas S. Hays, Adam W. Avery
Format: Article
Language:English
Published: Nature Portfolio 2022-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-05762-2
_version_ 1818887698005360640
author Sarah A. Denha
Alexandra E. Atang
Thomas S. Hays
Adam W. Avery
author_facet Sarah A. Denha
Alexandra E. Atang
Thomas S. Hays
Adam W. Avery
author_sort Sarah A. Denha
collection DOAJ
description Abstract Recent structural studies of β-III-spectrin and related cytoskeletal proteins revealed N-terminal sequences that directly bind actin. These sequences are variable in structure, and immediately precede a conserved actin-binding domain composed of tandem calponin homology domains (CH1 and CH2). Here we investigated in Drosophila the significance of the β-spectrin N-terminus, and explored its functional interaction with a CH2-localized L253P mutation that underlies the neurodegenerative disease spinocerebellar ataxia type 5 (SCA5). We report that pan-neuronal expression of an N-terminally truncated β-spectrin fails to rescue lethality resulting from a β-spectrin loss-of-function allele, indicating that the N-terminus is essential to β-spectrin function in vivo. Significantly, N-terminal truncation rescues neurotoxicity and defects in dendritic arborization caused by L253P. In vitro studies show that N-terminal truncation eliminates L253P-induced high-affinity actin binding, providing a mechanistic basis for rescue. These data suggest that N-terminal sequences may be useful therapeutic targets for small molecule modulation of the aberrant actin binding associated with SCA5 β-spectrin and spectrin-related disease proteins.
first_indexed 2024-12-19T16:41:21Z
format Article
id doaj.art-46b4e8567b9142cfb5b041cfd820729c
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-19T16:41:21Z
publishDate 2022-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-46b4e8567b9142cfb5b041cfd820729c2022-12-21T20:13:47ZengNature PortfolioScientific Reports2045-23222022-02-0112111110.1038/s41598-022-05762-2β-III-spectrin N-terminus is required for high-affinity actin binding and SCA5 neurotoxicitySarah A. Denha0Alexandra E. Atang1Thomas S. Hays2Adam W. Avery3Department of Chemistry, Oakland UniversityDepartment of Chemistry, Oakland UniversityDepartment of Genetics, Cell Biology and Development, University of MinnesotaDepartment of Chemistry, Oakland UniversityAbstract Recent structural studies of β-III-spectrin and related cytoskeletal proteins revealed N-terminal sequences that directly bind actin. These sequences are variable in structure, and immediately precede a conserved actin-binding domain composed of tandem calponin homology domains (CH1 and CH2). Here we investigated in Drosophila the significance of the β-spectrin N-terminus, and explored its functional interaction with a CH2-localized L253P mutation that underlies the neurodegenerative disease spinocerebellar ataxia type 5 (SCA5). We report that pan-neuronal expression of an N-terminally truncated β-spectrin fails to rescue lethality resulting from a β-spectrin loss-of-function allele, indicating that the N-terminus is essential to β-spectrin function in vivo. Significantly, N-terminal truncation rescues neurotoxicity and defects in dendritic arborization caused by L253P. In vitro studies show that N-terminal truncation eliminates L253P-induced high-affinity actin binding, providing a mechanistic basis for rescue. These data suggest that N-terminal sequences may be useful therapeutic targets for small molecule modulation of the aberrant actin binding associated with SCA5 β-spectrin and spectrin-related disease proteins.https://doi.org/10.1038/s41598-022-05762-2
spellingShingle Sarah A. Denha
Alexandra E. Atang
Thomas S. Hays
Adam W. Avery
β-III-spectrin N-terminus is required for high-affinity actin binding and SCA5 neurotoxicity
Scientific Reports
title β-III-spectrin N-terminus is required for high-affinity actin binding and SCA5 neurotoxicity
title_full β-III-spectrin N-terminus is required for high-affinity actin binding and SCA5 neurotoxicity
title_fullStr β-III-spectrin N-terminus is required for high-affinity actin binding and SCA5 neurotoxicity
title_full_unstemmed β-III-spectrin N-terminus is required for high-affinity actin binding and SCA5 neurotoxicity
title_short β-III-spectrin N-terminus is required for high-affinity actin binding and SCA5 neurotoxicity
title_sort β iii spectrin n terminus is required for high affinity actin binding and sca5 neurotoxicity
url https://doi.org/10.1038/s41598-022-05762-2
work_keys_str_mv AT sarahadenha biiispectrinnterminusisrequiredforhighaffinityactinbindingandsca5neurotoxicity
AT alexandraeatang biiispectrinnterminusisrequiredforhighaffinityactinbindingandsca5neurotoxicity
AT thomasshays biiispectrinnterminusisrequiredforhighaffinityactinbindingandsca5neurotoxicity
AT adamwavery biiispectrinnterminusisrequiredforhighaffinityactinbindingandsca5neurotoxicity